Global sequence diversity of BRCA2: Analysis of 71 breast cancer families and 95 control individuals of worldwide populations

Human Molecular Genetics

Volumn 8, Issue 3, 1999, Pages 413-423

  Wagner, Teresa M U ^a   Hirtenlehner, Kora ^a   Shen, Peidong ^c   Moeslinger, Regin ^a   Muhr, Daniela ^a   Fleischmann, Elisabeth ^a,b   Concin, Hans ^d   Doeller, Walter ^d   Haid, Anton ^d   Lang, Alois Hermann ^a   Mayer, Peter ^d   Petru, Edgar ^e   Ropp, Erich ^f   Langbauer, Gudrun ^a   Kubista, Ernst ^a,b   Scheiner, Otto ^a   Underhill, Peter ^c   Mountain, Joanna ^c   Stierer, Michael ^g   Zielinski, Cristoph ^a,b   Oefner, Peter ^c   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c STANFORD UNIVERSITY   (United States)

^d Department of Surgery ^*  (Austria)

^e UNIVERSITY OF GRAZ   (Austria)

^f GENERAL HOSPITAL KLAGENFURT   (Austria)

^g HANUSCH HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; LEUCINE;

AFRICA; ARTICLE; BREAST CANCER; CODON; CONTROLLED STUDY; DELETION MUTANT; DNA DENATURATION; DNA POLYMORPHISM; ETHNOLOGY; EXON; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTRON; MISSENSE MUTATION; NONSENSE MUTATION; OVARY CANCER; POPULATION GENETICS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SILENT GENE; SITE DIRECTED MUTAGENESIS; STOP CODON;

AFRICA; BASE SEQUENCE; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MUTATION; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PEDIGREE; TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 0033054176     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Manglon, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs, P., Hashim, Y., Smith, A., Connor, F., Arason, A., Gudmundsson, J., Ficenec, D., Kelsell, D., Ford, D., Tonin, P., Bishop, D.T. et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789-792.
2. Tavtigian, S.V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., Belanger, C., Bell, R., Berry, S., Bogden, R., Chen, Q., Davis, T., Dumont, M., Frye, C., Hattier, T., Jammulapati, S., Janecki, T., Jiang, P., Kehrer, R., Leblanc, J.-F., Mitchell, J.T. et al. (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet., 12, 333-337.
3. Breast Cancer Information Core-database (http://www.nhgri.nih.gov/ Intramural_research/Lab_transfer/Bic/ ).
4. Sharan, S.K., Morimatsu, M., Albrecht, U., Lim, D.-S., Regel, E., Dinh, C., Sands, A., Eichelle, G., Hasty, P. and Bradley, A. (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2. Nature, 386, 804-810.
5. Wong, A.K.C., Pero, R., Ormonde, P.A., Tavtigian, S.V. and Bartel, P.L. (1997) RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene BRCA2. J. Biol. Chem., 272, 31941-31944.
6. Zhang, H., Tombline, G. and Weber, B.L. (1998) BRCA1, BRCA2, and DNA damage response: collision or collusion? Cell, 92, 433-436.
7. Chen, P.-L., Chen, C-F., Chen, Y., Xiao, J., Sharp, Z.D. and Lee, W.-H. (1998) The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc. Natl Acad. Sci. USA. 95. 5287-5292.
8. Katagiri, T., Saito, H., Akira, S., Ogawa, H., Kamada, N., Nakamura, Y. and Miki, Y. (1998) Multiple possible sites of BRCA2 interacting with DNA repair protein RAD51. Genes Chromosomes Cancer, 21, 217-222.
9. Schrijver, I., Liu, W, and Francke, U. (1997) The pathogenicity of the Pro1148Ala substitution in the FBN1 gene: causing or predisposing to Marfan syndrome and aortic aneurysm, or clinically innocent? Hum. Genet., 99, 607-611.
10. Liu, W., Smith, D.I., Rechtzigel, K.J., Thibodeau, S.N. and James, C.D. (1998) Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res., 26, 1396-1400.
11. O'Donovan, M.C., Oefner, P.J., Roberts, S.C., Austin, J., Hoogendoom, B., Guy, C., Speight, G., Upadhyaya, M., Sommer, S.S. and McGuffin, P. (1998) Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics, 52, 44-49.
12. Hakansson, S., Johannsson, O., Johansson, U., Sellberg, G., Loman, N., Gerdes, A.-M., Holmberg, E., Dahl, N., Pandis, N., Kristoffersson, U., Olsson, H. and Borg, A. (1997) Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am. J. Hum. Genet., 60, 1068-1078.
13. Schubert, E.L., Lee, M.K., Mefford, H.C., Argonza, R.H., Morrow, J.E., Hull. J., Dann, J.L. and King, M.-C. (1997) BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am. J. Hum. Genet., 60, 1031-1040.
14. Haraldsson, K., Loman, N., Zhang, Q.-X., Johannson, O., Olsson, H. and Borg, A. (1998) BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res., 58, 1367-1371.
15. Teng, D.H.-F., Bogden, R., Mitchell, J., Baumgard, M., Bell, R., Berry, S., Davis, T., Ha, P.C., Kehrer, R., Jammulapati, S., Chen, Q., Offit, K., Skolnick, M.H., Tavtigian, S.V., Jhanwar, S., Swedlund, B., Wong, A.K.C. and Kamb, A. (1996) Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nature Genet., 13, 241-244.
16. Couch, F.J., Fand, L.M., DeShano, M.L., Tavtigian, S.V., Calzone, K., Campeau, L., Peng, Y., Bogden, B., Chen, Q., Neuhausen, S., Shattuck-Eidens, D., Godwin, A.K., Daly, M., Radford, D.M., Sedlacek, S., Rommens, J., Simard, J., Garber, J., Merajver, S. and Weber, B.L. (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genet., 13, 123-125.
17. McAllister, K.A., Haugen-Strano, A., Hagevik, S., Brownlee, H.A., Collins, N.K., Futreal, P.A., Bennett, L.M. and Wiseman, R.W. (1997) Characterization of the rat and mouse homologues of the BRCA2 breast cancer susceptibility gene. Cancer Res., 57, 3121-3125.
18. Takahashi, H., Chiu, H.-C., Bandera, C.A., Behbakht, K., Liu, P.C., Couch, F.J., Weber, B.L., LiVolsi, V.A., Furusato, M., Rebane, B.A., Cardonick, A., Benjamin, I., Morgan, M.K., King, S.A., Mikuta, J.J., Rubin, S.C. and Boyd, J. (1996) Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res., 56, 2738-2741.
19. Mavraki, E., Gray, J., Bishop, D. and Spurr, N. (1997) Germline BRCA2 mutations in men with breast cancer. Br. J. Cancer, 76, 1428-1431.
20. Vehmanen, P., Friedman, L.S., Eerola, H., Sarantaus, L., Pyrhönen, S., Ponder, B.A.J., Muhonen, T. and Nevanlinna, H. (1997) A low proportion of BRCA2 mutations in Finnish breast cancer families. Am. J. Hum. Genet., 60, 1050-1058.
21. Mazoyer, S., Dunning, A.M., Serova, O., Dearden, J., Puget, N., Healey, C.S., Gayther, S.A., Mangion, J., Stratton, M.R., Lynch, H.T., Goldgar, D.E., Ponder, B.A.J. and Lenoir, G.M. (1996) A polymorphic stop codon in BRCA2. Nature Genet., 14, 253-254.
22. Wagner, T.M.U., Möslinger, R.A., Muhr, D., Langbauer, G., Hirtenlehner, K., Concin, H., Doeller, W., Haid, A., Lang, A.H., Mayer, P., Ropp, E., Kubista, E., Amirimani, B., Helbich, T., Becherer, A., Scheiner, O., Breiteneder, H., Borg, A., Devilee, P., Oefner, P. and Zielinski, C. (1998) BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int. J. Cancer, 77, 354-360.
23. Gayther, S.A., Mangion, J., Russell, P., Seal, S., Barfoot, R., Ponder, B.A.J., Stratton, M.R. and Easton, D. (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nature Genet., 15, 103-105.
24. Koonin, E.V., Altschul, S.F. and Bork, P. (1996) Functional motifs. Nature Genet., 13, 266-267.
25. Bork, P., Blomberg, N. and Nilges, M. (1996) Internal repeats in the BRCA2 protein sequence. Nature Genet., 13, 22-23.
26. Liu, W., Qian, C. and Francke, U. (1997) Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nature Genet., 16, 328-329.
27. Richard, I.A. and Beckmann, J.S. (1995) How neutral are synonymouscodon mutations? Nature Genet., 10, 259.
28. Bignell, G., Micklem, G., Stratton, M.R., Ashworth, A. and Wooster, R. (1997) The BRC repeats are conserved in mammalian BRCA2 proteins. Hum. Mol. Genet., 6, 53-58.
29. Petrij-Bosch, A., Peelen, T., van Vliet, M., van Eijk, R., Olmer, R., Drüsedau, M., Hogervorst, F.B.L., Hageman, S., Arts, P.J.W., Ligtenberg, M.J.L., Meijers-Heijboer, H., Klijn, J.G.M., Vasen, H.F.A., Comelisse, C.J., van't Veer, L.J., Bakker, E., van Ommen, G.-J.B. and Devilee, P. (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer cases. Nature Genet., 17, 341-345.
30. Wang, D.G., Fan, J.-B., Siao, C.-J., Berno, A., Young, P., Sapolsky, R., Ghandour, G., Perkins, N., Winchester, E., Spencer, J., Kniglyak, L., Stein, L., Hsie, L., Topaloglou, T., Hubbell, E., Robinson, E., Mittmann, M., Morris, M.M., Shen, N., Kilburn, D., Rioux, J., Nusbaum, C., Rozen, S., Hudson, T.J., Lipshutz, R., Chee, M. and Lander, E.S. (1998) Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science, 280, 1077-1082.
31. Nickerson, D.A., Taylor, S.L., Weiss, K.M., Clark, A.G., Hutchinson, R.G., Stengård, J., Salomaa, V., Vartiainen, E., Boerwinkle, E. and Sing, C.F. (1998) DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nature Genet., 19, 233-240.
32. Godwin, A.K., Vanderveer, L., Schultz., D.C., Lynch, H.A.T., Altomare, D.A., Buetow, K.H. and Daly, M. (1994) A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. Am. J. Hum. Genet., 55, 666-677.
33. Oefner, P.J. and Underhill, P.A. (1995) Comparative DNA sequencing by denaturing high-performance liquid chromatography (DHPLC). Am. J. Hum. Genet., 57, A266.
34. Hayward-Lester, A., Chilton, B.S., Underhill, P.A., Oefner, P.J. and Doris, P.A. (1997) Quantification of specific nucleic acids, regulated RNA processing and genomic polymorphisms using reversed-phase HPLC. In Ferré, F. (ed.). Gene Quantification. Birkhäuser Verlag, Basel, Switzerland, pp. 44-77.
35. Oefner, P.A. and Underhill, P. (1998) DNA mutation detection using denaturing high performance liquid chromatography (DHPLC). Current Protocols in Human Genetics. Wiley & Sons, New York. Supplement 19, 7.10.1-7.10.12.